In lung adenocarcinoma and glioma, studies have shown that SAE1 expression upregulation promoted AKT sumoylation, further promoting AKT phosphorylation, thereby activating the AKT signaling pathway [11, 17]. The gene discussed is SAE1; the disease is central nervous system cancer.